Pangrol (Pancreas Powder)

Pancreas Powder, the active ingredient in Pangrol, is a pharmaceutical substance presented as an oral powder for oral use. It is supplied for investigational, research or supplemental purposes where appropriate. GNH USA supplies Pangrol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pangrol contains Pancreas Powder, which is currently listed without specific therapeutic indications in publicly available sources. - Research use: employed in laboratory studies investigating pancreatic function. - Supplemental use: sometimes used as a dietary supplement to support digestive health, though clinical evidence is limited. - Investigational use: may be included in clinical trials exploring enzyme replacement therapies.

Adverse reaction information for Pangrol is limited; no comprehensive safety profile has been published. Common Side Effects: - None reported: no common adverse events have been documented in the available literature. - Mild gastrointestinal discomfort: occasional reports of mild stomach upset. - Allergic reaction: rare cases of hypersensitivity have been noted. Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): extremely rare but reported in isolated cases. - Pancreatitis exacerbation: potential risk in patients with existing pancreatic disease, though not well characterized.

When handling Pangrol, standard pharmaceutical precautions should be observed due to limited safety data. - Verify identity: confirm product label matches Pancreas Powder specifications. - Assess suitability: avoid use in patients with known hypersensitivity to pancreatic enzymes. - Monitor clinical response: observe for unexpected gastrointestinal symptoms. - Limit exposure: handle with gloves to prevent accidental ingestion. - Store at ambient temperature: keep below 25°C in original packaging, protect from moisture.

Potential drug interactions for Pangrol have not been extensively studied; caution is advised when co‑administering with certain medications. Major Interactions (Avoid): - Antacids: may reduce enzyme activity when taken simultaneously. - Protease inhibitors: could interfere with pancreatic enzyme function. Moderate Interactions (Monitor Closely): - Oral anticoagulants: monitor INR as gastrointestinal changes may affect absorption. - Diabetes medications: monitor blood glucose if digestive absorption is altered. - Fat‑soluble vitamin supplements: absorption may be affected.